AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 21,250
-5,050 (-19.20%)
At close: Aug 20, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 584.57 billion as of August 20, 2026. Its market cap has increased by 17.95% in one year.
Market Cap
584.57B
Enterprise Value
504.38B
Revenue
725.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
21,250.00
ChartMarket Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 584.57B, an increase of 154.44%. That is a compound annual growth rate of 25.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 584.57B | -54.12% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.69T |
| JS Link | 1.32T |
| Qurient | 1.00T |
| Rznomics | 894.55B |
| ROKIT Healthcare | 495.75B |
| Inventage Lab | 404.96B |
| Curocell | 374.59B |
| IntoCell | 314.71B |